Broad Institute to implement low-volume DNA sequencing process using Deerac’s Equator™ products
Dublin, Ireland, 13 January 2005: The Broad Institute of MIT and Harvard (Cambridge, MA) is installing several Equator™ low volume pipetting systems from Deerac Fluidics (Dublin, Ireland) as part of a redesign of their production sequencing process.
As one of the world’s largest genome sequencing centres, the Broad Institute has selected Deerac technology as a key part of their next generation processes.
Joe Graham, a member of the production sequencing development team at the Broad Institute commented "After successfully validating Deerac’s Equator platform for our current process we have decided to implement it as part of our production line. This will generate substantial cost savings in the short term and make future cost reduction feasible. By offering the possibility of nanoliter dispensing, the Equator will allow us to better control our reagent yields and further optimize our process."
About Broad Institute
The Eli and Edythe L. Broad Institute is a research collaboration of the Massachusetts Institute of Technology, Harvard University and affiliated hospitals, and the Whitehead Institute for Biomedical Research. It was catalyzed in 2003 with the scientific goal of creating tools for genomic medicine and making them broadly available to the scientific community, while at the same time applying these tools to propel the understanding and treatment of disease.
About Deerac Fluidics
Deerac Fluidics is a leading provider of low-volume liquid handling solutions for the life science and pharmaceutical markets. Based on the proprietary spot-on™ technology, Deerac Fluidics offer microliter and nanoliter liquid handling systems for genomics, proteomics, and high-throughput screening applications.
For further information contact
Dr Jürgen Osing, CEO
Deerac Fluidics
Tel: +353 (1) 679 1464
Email: jurgen@deerac.com
www.deerac.com
|
Home